Historical data show the prevalence of pulmonary arterial hypertension (PAH) in adult patients with congenital heart disease ...

The programme includes the ECLIPSE 1 and ECLIPSE 2 Phase III trials, aiming to offer registrational data for regulatory ...

There is only a small evidence base supporting the application of current heart failure guidelines to the treatment of heart failure in adults with CHD. Medications and pacing interventions used ...

Wearable equipment-based telemedical management via multiparameter monitoring can help improve management in older patients with coronary heart disease.

Most readers would already be aware that Church & Dwight's (NYSE:CHD) stock increased significantly by 7.0% over the... Clorox (CLX) reported earnings 30 days ago. What's next for the stock?